Wednesday, January 06, 2021 4:20PM / NSE/ Header Image Credit: Ecographics
At the Board meeting of
Fidson Healthcare Plc which held on the 9th of December 2020, three (3) new Directors were appointed to the Board as follows:
1. Dr. Vincent
Ahonkhai, FAAP: Dr. Ahonkhai is an expert in Global Health and biopharmaceutical Research and Development. He is currently an independent Consultant and Principal at Gwynedd Consultancy, LLC in Pennsylvania, the USA from where he consults for organisations like Bill
& Melinda Gates Foundation amongst others. He will bring to the board, experience in Research & Development which is crucial to the
development of the pharmaceutical industry. He was appointed an Independent
Non-Executive Director.
2. Mr. Ekwunife Okoli:
Mr. Okoli is versatile in the field of Sales and Marketing, having worked for many years in the FMCG industry. He was an Executive Director, Marketing at Diageo Plc. He was also Managing
Director of the same company in Cameroun and Ghana and Managing Director for Africa and Regional Markets. He is an experienced Non-Executive Director who sits on the Board of Cornerstone Insurance Plc. He is married to
Mrs. Unoma Okoli and blessed with four children. He is expected to enrich the expertise in the Sales and Marketing department. He was appointed an Independent Non-Executive Director.
3. Ola Ijimakin:
Mr. ljimakin joined the organization (Fidson Healthcare Ltd) in July 2002 as Regional Manager in the North-eastern 80. By He graduated
from the University of Jos in 1994 where he was awarded a Bachelor of Pharmacy
(B.Pharm) degree. He won the prize for the best graduating student in Pharmacy
among other prestigious awards. He holds a Master of Business Administration
(MBA) degree from the Business School Netherlands, Buren (2014) where he finished
with a distinction.
Ola is a seasoned professional who has grown
through the ranks over the years. He served as Group Marketing Manager from May
2005 to December 2006; General Manager, Marketing from April 2011 to May 2016
and General Manager, Sales and Marketing from May 2016 till date.
Over the years, as GM Sales & Marketing, his
drive for results reflected in more than a 100% revenue sales growth from
N7.6bn to over N17bn.
He is vastly experienced, having served in large
corporations both at home and abroad. He is a fellow of the Pharmaceutical
Society of Nigeria.
His appointment as Commercial Director is a
testament to the hard work and commitment he has shown consistently over the
years. He was appointed as an Executive Director, Commercial.
The three appointments took effect from the 1st
of January 2021.
Visit Fidson Healthcare Plc IR Page in Proshare MARKETS
Graph - One Year Share Price Movement
Table: Q3 2020 Unaudited Results
Related News
1. FIDSON Declares N976m PAT in Q3 2020 Unaudited Results SP
N3.80K ...
2.
FIDSON Notifies of Board Meeting Date and
Commencement of Closed Period...
3. FIDSON
Declares N501m PAT in 2020 Q2 2020 Unaudited Results SP N3.15K ...
4. FIDSON To Hold 21st AGM on July 23 2020 Lists
Proxies...
5. FIDSON Declares N152m PAT in Q1 2020 Results SP
N2.96K ...
6. FIDSON Declares N437m PAT in 2019 Audited Results SP
N3.20K ...
7. FIDSON Declares N312m PAT in 2019 Q4 Unaudited Results...
8. FIDSON Declares 273mln Profit in Q3'19
Results;(SP:N4.00k)
9. Fidson Healthcare Plc Lists Additional 586,360,250
Ordinary Shares Issued by Way of a Rights Issue
10. FIDSON Declares N144.89m PAT in Q1 2019 Result,(SP:N4.20k)